Drugs used against ovarian cancer offer hope in tackling other forms of disease

The researchers said that exposing PBRM1-defective cancer cells to these drugs also activated the body’s anti-cancer immune response (David Davies/PA)
The researchers said that exposing PBRM1-defective cancer cells to these drugs also activated the body’s anti-cancer immune response (David Davies/PA)